Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemias

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00098826
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:23.617682+00:00
Published At
2013-01-11T00:00:00+00:00
Record Updated At
2013-01-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Undifferentiated Leukemia", "Adult Acute Megakaryoblastic Leukemia (M7)", "Adult Acute Minimally Differentiated Myeloid Leukemia (M0)", "Adult Acute Monoblastic Leukemia (M5a)", "Adult Acute Monocytic Leukemia (M5b)", "Adult Acute Myeloblastic Leukemia With Maturation (M2)", "Adult Acute Myeloblastic Leukemia Without Maturation (M1)", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Adult Acute Myelomonocytic Leukemia (M4)", "Adult Acute Promyelocytic Leukemia (M3)", "Adult Erythroleukemia (M6a)", "Adult Pure Erythroid Leukemia (M6b)", "Blastic Phase Chronic Myelogenous Leukemia", "de Novo Myelodysplastic Syndromes", "Previously Treated Myelodysplastic Syndromes", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Refractory Anemia With Excess Blasts", "Refractory Anemia With Excess Blasts in Transformation", "Relapsing Chronic Myelogenous Leukemia", "Secondary Acute Myeloid Leukemia", "Secondary Myelodysplastic Syndromes", "Untreated Adult Acute Myeloid Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-01-11"
protocolSection.identificationModule.nctId
"NCT00098826"
protocolSection.identificationModule.officialTitle
"Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemias"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Acute Undifferentiated Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Acute Megakaryoblastic Leukemia (M7) (protocolSection.conditionsModule.conditions)
  • Adult Acute Minimally Differentiated Myeloid Leukemia (M0) (protocolSection.conditionsModule.conditions)
  • Adult Acute Monoblastic Leukemia (M5a) (protocolSection.conditionsModule.conditions)
  • Adult Acute Monocytic Leukemia (M5b) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloblastic Leukemia With Maturation (M2) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloblastic Leukemia Without Maturation (M1) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myelomonocytic Leukemia (M4) (protocolSection.conditionsModule.conditions)
  • Adult Acute Promyelocytic Leukemia (M3) (protocolSection.conditionsModule.conditions)
  • Adult Erythroleukemia (M6a) (protocolSection.conditionsModule.conditions)
  • Adult Pure Erythroid Leukemia (M6b) (protocolSection.conditionsModule.conditions)
  • Blastic Phase Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • de Novo Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Previously Treated Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts in Transformation (protocolSection.conditionsModule.conditions)
  • Relapsing Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Secondary Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Secondary Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Untreated Adult Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.